Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells
Epigenetic modifiers are an emerging class of anti-tumor drugs, potent in multiple cancer contexts. Their effect on spontaneously developing autoimmune diseases has been little explored. We report that a short treatment with I-BET151, a small-molecule inhibitor of a family of bromodomain-containing...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/04631 |